Study of Pre-operative Combination Therapy With Mogamulizumab and Nivolumab Against Solid Cancer Patients
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02946671|
Recruitment Status : Completed
First Posted : October 27, 2016
Last Update Posted : March 6, 2020
Kyowa Kirin Co., Ltd.
Ono Pharmaceutical Co. Ltd
Clinical Study Support, Inc.
Fiverings Co., Ltd.
Information provided by (Responsible Party):
Hisashi Wada, Osaka University
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Completed|
|Actual Primary Completion Date :||March 2020|
|Actual Study Completion Date :||March 2020|